Clopine Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

clopine

douglas pharmaceuticals limited - clozapine 25mg;   - tablet - 25 mg - active: clozapine 25mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Clopine Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

clopine

douglas pharmaceuticals limited - clozapine 50mg;   - tablet - 50 mg - active: clozapine 50mg   excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified water sodium starch glycolate - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Versacloz Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

versacloz

douglas pharmaceuticals limited - clozapine 50 mg/ml - oral suspension - 50 mg/ml - active: clozapine 50 mg/ml excipient: glycerol hydrochloric acid monobasic sodium phosphate dihydrate povidone sodium hydroxide sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol water xanthan gum - indicated in the treatment of resistant schizophrenic patients only (i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics). non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

DP-Captopril Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dp-captopril

douglas pharmaceuticals limited - captopril 5 mg/ml - oral solution - 5 mg/ml - active: captopril 5 mg/ml excipient: citric acid monohydrate disodium edetate purified water sodium benzoate sodium citrate - dp-captopril is indicated for the treatment of hypertension. in using dp-captopril, consideration should be given to the risk of neutropenia/agranulocytosis (see section 4.4 special warnings and precautions for use). dp-captopril is effective alone and in combination with other antihypertensive agents, especially thiazide-type diuretics. the blood pressure lowering effects of captopril and thiazides are approximately additive.

Dexiclo Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dexiclo

douglas pharmaceuticals limited - ciclosporin 100mg - soft gelatin capsule - 100 mg - active: ciclosporin 100mg excipient: ethyl lactate gelatin glycerol iron oxide black lecithin medium-chain triglycerides peg-40 castor oil polysorbate 20 purified water sorbitan oleate titanium dioxide - solid organ transplantation: - prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allergenic transplantations. - treatment of transplant rejection in patients previously receiving other immunosuppressive agents.

Dexiclo Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dexiclo

douglas pharmaceuticals limited - ciclosporin 25mg - soft gelatin capsule - 25 mg - active: ciclosporin 25mg excipient: ethyl lactate gelatin glycerol iron oxide black lecithin medium-chain triglycerides peg-40 castor oil polysorbate 20 purified water sorbitan oleate titanium dioxide - solid organ transplantation: - prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allergenic transplantations. - treatment of transplant rejection in patients previously receiving other immunosuppressive agents.

Dexiclo Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dexiclo

douglas pharmaceuticals limited - ciclosporin 50mg - soft gelatin capsule - 50 mg - active: ciclosporin 50mg excipient: ethyl lactate gelatin glycerol lecithin medium-chain triglycerides peg-40 castor oil polysorbate 20 purified water sorbitan oleate titanium dioxide - solid organ transplantation: - prevention of graft rejection following kidney, liver, heart, combined heart-lung, lung or pancreas allergenic transplantations. - treatment of transplant rejection in patients previously receiving other immunosuppressive agents.

DP-Anastrozole Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dp-anastrozole

douglas pharmaceuticals limited - anastrozole 1mg - film coated tablet - 1 mg - active: anastrozole 1mg excipient: hypromellose lactose monohydrate magnesium stearate opadry white y-1-7000 povidone sodium starch glycolate - treatment of advanced breast cancer in post-menopausal women.

DP-Quetiapine Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dp-quetiapine

douglas pharmaceuticals limited - quetiapine fumarate 115.13mg equivalent to quetiapine 100 mg;   - film coated tablet - 100 mg - active: quetiapine fumarate 115.13mg equivalent to quetiapine 100 mg   excipient: calcium hydrogen phosphate dihydrate hypromellose iron oxide yellow lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - dp-quetiapine is indicated for the treatment of: - acute and chronic psychoses, including schizophrenia.

DP-Quetiapine Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

dp-quetiapine

douglas pharmaceuticals limited - quetiapine fumarate 230.31mg equivalent to quetiapine 200 mg;   - film coated tablet - 200 mg - active: quetiapine fumarate 230.31mg equivalent to quetiapine 200 mg   excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide - dp-quetiapine is indicated for the treatment of: - acute and chronic psychoses, including schizophrenia.